Bush agenda favorable to biopharm market? In theory, at least: what will four more years of President Bush mean for the biopharmaceutical industry?(StreetTalk)(Industry Overview)

I wrote in the December 2005 issue of Streetalk that no matter who won the election between George Bush and John Kerry the follow would have been beneficial news to the biopharm industry--if for different reasons. I said that with President Bush back in office for a next to the first term, industry red tape would be diminished and the life sciences sector would shift into higher gear.

on the other hand that was before the Vioxx scare. Now you can be fully convinced Uncle Sam will be scrutinizing medicine companies very closely after widespread media coverage--much of it negative--rattled the biopharm industry. That's